Supply Chain

1. Balancing Innovation With Manufacturability When GMP-Grade Is Unavailable 12/4/2025

   Some raw materials simply aren't available in GMP. Experts Yan Zhi and Lawrence Thompson describe risk assessment approaches that inform sourcing decisions in this segment from Cell & Gene Live "Viability On The Line." Some investigational therapies require many unique raw materials, and controlling them appropriately gets tricky. Complexities also vary by modality and batch size. Control strategies must be adaptable.

2. Supporting The Global Biopharma Industry With Single-Use Capacity Expansion 4/22/2022

   Explore Cytiva’s brand new single-use production facility in Wales, UK. This facility forms part of Cytiva’s >$1.5 billion investment in increased capacity to support the growing needs of the biopharmaceutical industry and to increase regional supply.

3. Comparing Manual Vs. Automated Processing And Thawing Systems 4/15/2025

   In this segment of our Cell & Gene Live, Optimizing Storage Solutions for iPSCs, expert panelists Pratik Jaluria, Ph.D., SVP Technical Development Strategy at BlueRock Therapeutics, Bruno Marques, Ph.D. VP, Process and Product Development at Century Therapeutics, and Kate Rochlin, Ph.D., COO at IN8bio share that a well-constructed manual operation can be matched by an automated system, but there is a higher capital expenditure.

4. Microcarrier Separation Systems 11/3/2022

   Ross Acucena, applications director, and Donnie Beers, product manager, introduce our highly functional and adaptable microcarrier cell separation bags designed for single-use processes. 

5. Thermo Fisher Scientific Single-Use Global Manufacturing Network 4/18/2022

   We have implemented a multi-tier strategy to improve the resiliency of our supply chain and created the largest networked single-use manufacturing organization in the world.

6. A Dedicated Team To Safely Store Your Cell And Virus Banks 2/27/2023

   The safety of your cell and virus banks must be your top priority. Learn about a team dedicated to the safety of your material along with their related services.

7. mRNA For Cancer Immunotherapy 2024 Outlook | Audience Q&A 1/29/2024

   During our Cell & Gene Live, mRNA For Cancer Immunotherapy 2024 Outlook, our expert panelists answered audience questions regarding patient safety, foreseeable challenges in mRNA cancer immunotherapy for solid tumors, and much more.

8. Storing Your Banks With Ease And Confidence 2/17/2023

   Discover a biorepository that will fulfill your need of long-term and short-term storage. You can never be too careful with your cell or virus banks. Explore three global sites that will ensure the safety of your bank.

9. Bridging The Gap Between Lab Development And GMP Manufacturing 4/15/2025

   In this first segment of Cell & Gene Live, Optimizing Storage Solutions for iPSCs, expert panelists Pratik Jaluria, Ph.D., SVP Technical Development Strategy at BlueRock Therapeutics, Bruno Marques, Ph.D. VP, Process and Product Development at Century Therapeutics, and Kate Rochlin, Ph.D., COO at IN8bio focus on best practices for translating laboratory development processes into CGMP manufacturing settings.

10. Risk Mitigation Strategies 11/13/2023

    In this segment, Umoja's Co-Founder and CTO Ryan Crisman and BMS’ Global Head, Cell Therapy Logistics and Shipping Systems, Rookie Gleich explain some of the key risk management mitigation issues regarding managing temperature before, during, and after transit.